Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

VY-3-135

🥰Excellent
Catalog No. T9732Cas No. 1824637-41-3

VY-3-135 is an orally active, stable and specific acetyl-CoA synthetase 2 (ACSS2) inhibitor with IC50 of 44 nM, showing no inhibitory activity against recombinant human ACSS1 or ACSS3. VY-3-135 can effectively inhibit ACSS2-dependent fatty acid metabolism but has no effect on gene expression in tumors.

VY-3-135

VY-3-135

🥰Excellent
Purity: 99.25%
Catalog No. T9732Cas No. 1824637-41-3
VY-3-135 is an orally active, stable and specific acetyl-CoA synthetase 2 (ACSS2) inhibitor with IC50 of 44 nM, showing no inhibitory activity against recombinant human ACSS1 or ACSS3. VY-3-135 can effectively inhibit ACSS2-dependent fatty acid metabolism but has no effect on gene expression in tumors.
Pack SizePriceAvailabilityQuantity
1 mg92 €In Stock
5 mg187 €In Stock
10 mg311 €In Stock
25 mg530 €In Stock
50 mg748 €In Stock
100 mg1.064 €In Stock
500 mg2.118 €In Stock
1 mL x 10 mM (in DMSO)227 €In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "VY-3-135"

Select Batch
Purity:99.25%
Contact us for more batch information
Resource Download
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.

Product Introduction

Bioactivity
Description
VY-3-135 is an orally active, stable and specific acetyl-CoA synthetase 2 (ACSS2) inhibitor with IC50 of 44 nM, showing no inhibitory activity against recombinant human ACSS1 or ACSS3. VY-3-135 can effectively inhibit ACSS2-dependent fatty acid metabolism but has no effect on gene expression in tumors.
In vitro
METHODS: BT474 cells were treated with VY-3-135 (0.01, 0.1, 1 μM), and SKBr3 cells were treated with VY-3-135 (1 μM).
RESULTS VY-3-135 completely blocked fatty acid synthesis from acetate in SKBr3 cells. VY-3-135 is an effective targeted ACSS2 inhibitor in cells. [1]
In vivo
METHODS: BT474-transplanted mice were randomly assigned and treated with VY-3-135 (100 mg/kg) by intraperitoneal (IP) injection or oral gavage. Tumor size was measured in mice.
RESULTS VY-3-135 inhibited the growth of MDA-MB-468 (ACSS2 high) tumors but had no effect on WHIM12 (ACSS2 low) tumors. [1]
Chemical Properties
Molecular Weight429.51
FormulaC26H27N3O3
Cas No.1824637-41-3
SmilesCCn1c(nc2ccc(cc12)C(=O)NC[C@@H](C)O)C(O)(c1ccccc1)c1ccccc1
Relative Density.1.21 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 50 mg/mL (116.41 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3282 mL11.6412 mL23.2823 mL116.4117 mL
5 mM0.4656 mL2.3282 mL4.6565 mL23.2823 mL
10 mM0.2328 mL1.1641 mL2.3282 mL11.6412 mL
20 mM0.1164 mL0.5821 mL1.1641 mL5.8206 mL
50 mM0.0466 mL0.2328 mL0.4656 mL2.3282 mL
100 mM0.0233 mL0.1164 mL0.2328 mL1.1641 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy VY-3-135 | purchase VY-3-135 | VY-3-135 cost | order VY-3-135 | VY-3-135 chemical structure | VY-3-135 in vivo | VY-3-135 in vitro | VY-3-135 formula | VY-3-135 molecular weight